Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission

C. J. Langer, S. M. Keller, S. M. Erner

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background. Thymic hyperplasia after successful treatment of malignant disease is a well-documented phenomenon, particularly in younger patients with testicular carcinoma. However, it has been reported only sporadically in association with Hodgkin disease. The authors report the first instance of an adult with nodular sclerosing Hodgkin disease who had thymic hyperplasia develop after clinical and radiographic complete remission (CR) with chemotherapy alone. Methods. In addition to the current case, 20 other instances of thymic hyperplasia have been culled from the literature and analyzed. Results. The median age of these 21 patients was 23 years of age (range, 8-40 years of age). Thymic hyperplasia was noted after treatment was initiated or completed in all but two patients; and all did well, with one exception: a 17 year-old boy who was inadvertently treated for relapsed Hodgkin disease and who died of fibrinous pneumonitis and nocardia, with pathologic CR noted at autopsy. Conclusions. Thymic hyperplasia in association with Hodgkin disease appears to be a favorable prognostic phenomenon, restricted to younger patients in the first modal peak of Hodgkin incidence. Prospective studies have yet to be performed.

Original languageEnglish (US)
Pages (from-to)2082-2086
Number of pages5
JournalCancer
Volume70
Issue number8
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Thymus Hyperplasia
Hodgkin Disease
Hemorrhage
Drug Therapy
Nocardia
Autopsy
Pneumonia
Prospective Studies
Carcinoma
Incidence
Therapeutics

Keywords

  • Hodgkin disease
  • prognosis
  • thymic hyperplasia

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission. / Langer, C. J.; Keller, S. M.; Erner, S. M.

In: Cancer, Vol. 70, No. 8, 1992, p. 2082-2086.

Research output: Contribution to journalArticle

Langer, C. J. ; Keller, S. M. ; Erner, S. M. / Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission. In: Cancer. 1992 ; Vol. 70, No. 8. pp. 2082-2086.
@article{78c94da44a4447ceb96259f697d433ef,
title = "Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission",
abstract = "Background. Thymic hyperplasia after successful treatment of malignant disease is a well-documented phenomenon, particularly in younger patients with testicular carcinoma. However, it has been reported only sporadically in association with Hodgkin disease. The authors report the first instance of an adult with nodular sclerosing Hodgkin disease who had thymic hyperplasia develop after clinical and radiographic complete remission (CR) with chemotherapy alone. Methods. In addition to the current case, 20 other instances of thymic hyperplasia have been culled from the literature and analyzed. Results. The median age of these 21 patients was 23 years of age (range, 8-40 years of age). Thymic hyperplasia was noted after treatment was initiated or completed in all but two patients; and all did well, with one exception: a 17 year-old boy who was inadvertently treated for relapsed Hodgkin disease and who died of fibrinous pneumonitis and nocardia, with pathologic CR noted at autopsy. Conclusions. Thymic hyperplasia in association with Hodgkin disease appears to be a favorable prognostic phenomenon, restricted to younger patients in the first modal peak of Hodgkin incidence. Prospective studies have yet to be performed.",
keywords = "Hodgkin disease, prognosis, thymic hyperplasia",
author = "Langer, {C. J.} and Keller, {S. M.} and Erner, {S. M.}",
year = "1992",
doi = "10.1002/1097-0142(19921015)70:8<2082::AID-CNCR2820700812>3.0.CO;2-6",
language = "English (US)",
volume = "70",
pages = "2082--2086",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission

AU - Langer, C. J.

AU - Keller, S. M.

AU - Erner, S. M.

PY - 1992

Y1 - 1992

N2 - Background. Thymic hyperplasia after successful treatment of malignant disease is a well-documented phenomenon, particularly in younger patients with testicular carcinoma. However, it has been reported only sporadically in association with Hodgkin disease. The authors report the first instance of an adult with nodular sclerosing Hodgkin disease who had thymic hyperplasia develop after clinical and radiographic complete remission (CR) with chemotherapy alone. Methods. In addition to the current case, 20 other instances of thymic hyperplasia have been culled from the literature and analyzed. Results. The median age of these 21 patients was 23 years of age (range, 8-40 years of age). Thymic hyperplasia was noted after treatment was initiated or completed in all but two patients; and all did well, with one exception: a 17 year-old boy who was inadvertently treated for relapsed Hodgkin disease and who died of fibrinous pneumonitis and nocardia, with pathologic CR noted at autopsy. Conclusions. Thymic hyperplasia in association with Hodgkin disease appears to be a favorable prognostic phenomenon, restricted to younger patients in the first modal peak of Hodgkin incidence. Prospective studies have yet to be performed.

AB - Background. Thymic hyperplasia after successful treatment of malignant disease is a well-documented phenomenon, particularly in younger patients with testicular carcinoma. However, it has been reported only sporadically in association with Hodgkin disease. The authors report the first instance of an adult with nodular sclerosing Hodgkin disease who had thymic hyperplasia develop after clinical and radiographic complete remission (CR) with chemotherapy alone. Methods. In addition to the current case, 20 other instances of thymic hyperplasia have been culled from the literature and analyzed. Results. The median age of these 21 patients was 23 years of age (range, 8-40 years of age). Thymic hyperplasia was noted after treatment was initiated or completed in all but two patients; and all did well, with one exception: a 17 year-old boy who was inadvertently treated for relapsed Hodgkin disease and who died of fibrinous pneumonitis and nocardia, with pathologic CR noted at autopsy. Conclusions. Thymic hyperplasia in association with Hodgkin disease appears to be a favorable prognostic phenomenon, restricted to younger patients in the first modal peak of Hodgkin incidence. Prospective studies have yet to be performed.

KW - Hodgkin disease

KW - prognosis

KW - thymic hyperplasia

UR - http://www.scopus.com/inward/record.url?scp=0026783512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026783512&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19921015)70:8<2082::AID-CNCR2820700812>3.0.CO;2-6

DO - 10.1002/1097-0142(19921015)70:8<2082::AID-CNCR2820700812>3.0.CO;2-6

M3 - Article

C2 - 1382826

AN - SCOPUS:0026783512

VL - 70

SP - 2082

EP - 2086

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 8

ER -